Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Tarriff currently holds 460,621 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Tarriff has been a net seller of EGRX stock. They have purchased $0 and sold $24.4M worth of shares.
Scott Tarriff's most recent insider trade was on Feb 28, 2024, when they sold 2,119 shares at $6.27 per share.
Scott Tarriff serves as Executive at EAGLE PHARMACEUTICALS, INC. (EGRX). They have executed 81 insider transactions totaling $24.4M over their tenure at the company.
Scott Tarriff holds the position of Executive at EAGLE PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Scott Tarriff has shown a selling trading pattern, with $0 in total purchases and $24.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Scott Tarriff was on Mar 30, 2018, when they sold $3.1M worth of EGRX shares. This transaction involved 57,895 shares at $52.69 per share.
Scott Tarriff currently owns 460,621 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Tarriff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Tarriff has 81 Form 4 filings on record as an insider at EAGLE PHARMACEUTICALS, INC..
Set alerts for Scott Tarriff and 40,000+ other insiders.